for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Humana Inc

HUM

Latest Trade

428.49USD

Change

-7.70(-1.77%)

Volume

650,965

Today's Range

422.00

 - 

432.07

52 Week Range

370.22

 - 

475.44

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
436.19
Open
430.50
Volume
650,965
3M AVG Volume
16.33
Today's High
432.07
Today's Low
422.00
52 Week High
475.44
52 Week Low
370.22
Shares Out (MIL)
128.53
Market Cap (MIL)
56,065.37
Forward P/E
20.87
Dividend (Yield %)
0.64

Next Event

Humana Inc Meetings with UBS Clients

Latest Developments

More

Humana Reports Q3 2021 Financial Results Revises Full Year 2021 EPS Financial Guidance

Prophecy International Agrees To Provide eMite To Humana

Humana Inc Intends To Maintain FY 2021 NON-GAAP EPS GUIDANCE OF $21.25 TO $21.75

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Humana Inc

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or via group Medicare accounts. The Group and Specialty segment consists of employer group commercial insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members as well as to third parties, including pharmacy solutions, provider services, and clinical care service, such as home health and other services and capabilities to promote wellness and population health.

Industry

Healthcare Facilities

Contact Info

500 W Main St

LOUISVILLE, KY

40202

United States

+1.502.5801000

http://www.humana.com/

Executive Leadership

Kurt J. Hilzinger

Independent Chairman of the Board

Bruce D. Broussard

President, Chief Executive Officer, Director

Susan M. Diamond

Chief Financial Officer

William K. Fleming

Segment President, Clinical and Pharmacy Solutions

Christopher H. Hunter

Segment President, Group and Military Business

Key Stats

2.04 mean rating - 27 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

56.9K

2019

64.9K

2020

75.8K

2021(E)

83.3K
EPS (USD)

2018

14.550

2019

17.870

2020

18.750

2021(E)

20.533
Price To Earnings (TTM)
21.07
Price To Sales (TTM)
0.69
Price To Book (MRQ)
3.45
Price To Cash Flow (TTM)
17.11
Total Debt To Equity (MRQ)
76.88
LT Debt To Equity (MRQ)
70.52
Return on Investment (TTM)
--
Return on Equity (TTM)
6.20

Latest News

Latest News

Walgreens presses ex-law firm to disclose client records amid lawsuit

Walgreen Co has asked a Washington, D.C., judge to compel Crowell & Moring to disclose certain billing records for other healthcare clients, as the retail pharmacy giant pursues a lawsuit alleging its former firm violated confidences obtained from a prior representation.

Humana warns of hit to 2021 profit due to COVID-19 uncertainty

Humana Inc on Wednesday warned of a hit to annual earnings if demand for non-COVID healthcare services or coronavirus-related costs rise beyond the health insurer's expectations in the second half of the year.

Health insurer Humana's profit falls 68% on higher medical costs

Humana Inc reported a 67.8% fall in second-quarter profit on Wednesday, pressured by higher medical costs as vaccinated Americans opted for elective medical care that had been put on hold due to the pandemic.

Walgreens lawsuit against Crowell & Moring clears early hurdle

Washington, D.C.-based Crowell & Moring has lost an early bid to dismiss claims that it crossed ethical lines by squaring off against former client Walgreen Co in an arbitration over drug prices.

Hospital wins new trial in $20 million dispute with Humana over judge swap

Illinois' highest court has ordered a new trial in a lawsuit by a hospital accusing Humana Inc of cheating it out of $20 million, finding the trial court wrongly refused to let the hospital exercise its right under the state's law to switch judges.

Insurer Humana backs 2021 profit forecast as COVID-19 uncertainty lingers

Humana Inc on Wednesday cautiously stuck to its full-year adjusted earnings target after beating first-quarter profit estimates, taking into account the possibility of seniors reusing healthcare services deferred due to the pandemic.

Health insurer Humana profit surges 75%

U.S. health insurer Humana Inc reported a 75.1% rise in first-quarter profit on Wednesday, helped partly by higher revenue from its largest unit that offers Medicare plans.

Humana to buy rest of Kindred at Home for $5.7 billion to expand patient care

U.S. health insurer Humana Inc said on Tuesday it will acquire the 60% stake that it did not own in home health and hospice provider Kindred at Home from TPG Capital for $5.7 billion to expand its patient care business.

Humana to acquire remaining stake in Kindred at Home in $8.1 bln deal

U.S. health insurer Humana Inc said on Tuesday it will acquire remaining 60% stake in hospice provider Kindred at Home from TPG Capital for an enterprise value of $8.1 billion. (Reporting by Trisha Roy in Bengaluru; Editing by Arun Koyyur)

Humana CFO to step down

Health insurer Humana Inc said on Monday its Chief Financial Officer Brian Kane will step down from his position later this year in order to pursue broader career goals.

Insurer Humana expects COVID-19 costs to shrink in 2021 due to vaccinations

Health insurer Humana Inc said on Wednesday it expects costs related to COVID-19 treatment to decline in 2021 at a faster rate than demand for elective healthcare services to pick up, as more people get vaccinated against the new coronavirus.

Humana sees strong 2021 profit growth on Medicare Advantage strength

Health insurer Humana Inc <HUM.N> said on Tuesday it sees a boost to its 2021 profit from strong growth in its Medicare Advantage health plans.

Health insurer Humana's profit surges on deferred medical care

Humana Inc reported a 94.5% jump in its third-quarter profit on Tuesday, partly helped by customers delaying hospital visits and medical procedures due to the COVID-19 pandemic.

Health insurer Humana beats profit estimates on lower medical costs

Humana Inc <HUM.N> beat quarterly profit estimates and reaffirmed its full-year forecast on Wednesday, as the U.S. health insurer benefited from patients delaying non-emergency medical procedures due to the COVID-19 pandemic.

Health insurer Humana Q2 profit nearly doubles

Health insurer Humana Inc reported a 94.5% rise in quarterly profit on Wednesday, as it benefited from people delaying non-emergency medical procedures due to the COVID-19 pandemic.

Insurer Humana teams up with Walmart, Quest, LabCorp for COVID-19 testing

U.S. health insurer Humana Inc will offer its members at-home COVID-19 test collection kits, as well as provide access to drive-through testings at the hundreds of neighborhood markets of Walmart Inc, it said on Tuesday.

BRIEF-Humana To Offer Labcorp At-Home COVID-19 Test Collection, Collaborate With Walmart And Quest Diagnostics To Offer Drive-Thru Testing For Humana Members

* HUMANA TO OFFER LABCORP AT-HOME COVID-19 TEST COLLECTION AND COLLABORATE WITH WALMART AND QUEST DIAGNOSTICS TO OFFER DRIVE-THRU TESTING FOR HUMANA MEMBERS Source text for Eikon: Further company coverage:

BRIEF-Humana Announces Monthly Stipend To Reduce Costs For Dental Providers During Pandemic

* HUMANA ANNOUNCES MONTHLY STIPEND TO REDUCE COSTS FOR DENTAL PROVIDERS DURING PANDEMIC

BRIEF-Humana Awarded New Contract To Continue Serving Medicaid Managed Care Residents In Home State Of Kentucky

* HUMANA AWARDED NEW CONTRACT TO CONTINUE SERVING MEDICAID MANAGED CARE RESIDENTS IN HOME STATE OF KENTUCKY Source text for Eikon: Further company coverage:

BRIEF-Humana To Reaffirm Guidance Range Of $16.04 To $16.54 In Diluted Earnings Per Common Share For Year Ending December 31, 2020

* HUMANA - INTENDS TO REAFFIRM ITS GUIDANCE RANGE OF $16.04 TO $16.54 IN DILUTED EARNINGS PER COMMON SHARE FOR YEAR ENDING DECEMBER 31, 2020

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up